Back to top

Opko Health Launches Early MASH Trial That Could Shape Its Next Growth Chapter

Opko Health ($OPK) announced an update on their ongoing clinical study. Opko Health, Inc. is running a Phase 1/2 trial called “Safety, Tolerability...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

OPKO Health, Inc. (OPK)